- Monitoring Patients with Chronic HBV Infection During Antiviral Therapy
-
Kim YS
- KMID: 760572
- Korean J Hepatol.
- 2005 Mar;11(1):9-12.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis B virus reactivation during chlorambucil and prednisolone treatment in an HBsAg-negative and anti-HBs-positive patient with B-cell chronic lymphocytic leukemia
-
Lim SM, Jang JW, Kim BW, Choi H, Choi KY, Park SJ, Han CW
- KMID: 760786
- Korean J Hepatol.
- 2008 Jun;14(2):213-218.
- doi: 10.3350/kjhep.2008.14.2.213
It is generally accepted that seroconversion of hepatitis B virus (HBV) surface antigen (HBsAg) to an antibody to HBsAg (anti-HBs) indicates clearance of HBV. Here we report a case of... -
- CITED
-
- Close
- SHARE
-
- Close
- Localization of hepatitis B virus DNA in hepatocellular carcinoma by polymerase chain reaction in situ hybridization
-
Shin YJ, Cho SW, Hahm KB, Kim YS, Kim JH, Park KH, Lee SI
- KMID: 1038164
- J Korean Med Sci.
- 1998 Aug;13(4):377-382.
- doi: 10.3346/jkms.1998.13.4.377
The polymerase chain reaction in situ hybridization (PCR-ISH) is a new technique that combines the sensitivity of PCR with the localizing ability of ISH. To investigate the expression pattern... -
- CITED
-
- Close
- SHARE
-
- Close
- The Expression of Estrogen Receptors in Hepatocellular Carcinoma in Korean Patients
-
Wang AG, Lee KY, Kim SY, Choi JY, Lee KH, Kim WH, Wang HJ, Kim JM, Park MG, Yeom YI, Kim NS, Yu DY, Lee DS
- KMID: 1777170
- Yonsei Med J.
- 2006 Dec;47(6):811-816.
- doi: 10.3349/ymj.2006.47.6.811
Expression of estrogen receptors (ER)-alpha and -beta, as well as androgen receptor (AR), in hepatocellular carcinoma (HCC) is thought to be correlated with prognosis, survival, and male prevalence of HCC.... -
- CITED
-
- Close
- SHARE
-
- Close
- Meta-analysis of the correlation between the rs17401966 polymorphism in kinesin family member 1B and susceptibility to hepatitis B virus related hepatocellular carcinoma
-
Su M, Guo J, Huang J
- KMID: 2413117
- Clin Mol Hepatol.
- 2017 Jun;23(2):138-146.
- doi: 10.3350/cmh.2016.0083
BACKGROUND/AIMS: The association between the kinesin family member 1B (KIF1B) gene polymorphism and the risk of hepatitis B virus-related hepatocellular carcinoma (HCC) has been investigated in many peer-reviewed studies. However,... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Significances of Serum Soluble Fas and Soluble Fas Ligand in Chronic Hepatitis B
-
Jun EJ, Han JY, Sun HS
- KMID: 938254
- Korean J Hepatol.
- 2006 Dec;12(4):507-514.
BACKGROUND/AIMS: Apoptosis via Fas/FasL system is thought to be involved in the development of hepatocyte death in viral hepatitis B. In chronic hepatitis C, sFas/sFasL system was reported to... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis B core antigen expression pattern predicts response to lamivudine therapy in patients with chronic hepatitis B
-
Shi KD, Hwang SG, Choi JH, Hwang IJ, Yoon JH, Kim KI, Kwon CI, Hong SP, Park PW, Rim KS
- KMID: 760784
- Korean J Hepatol.
- 2008 Jun;14(2):197-205.
- doi: 10.3350/kjhep.2008.14.2.197
BACKGROUNDS/AIMS: Negative hepatitis B core antigen (HBcAg) staining in hepatocytes is indicative of viral replication by an active immune response. HBcAg is expressed mainly in the cytoplasm in patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic Efficacy of Lamivudine in Patients With Hepatitis B Virus-Related Decompensated Cirrhosis in Korea
-
Jung S, Suh DJ, Park HJ, Park YH, Song HG, Lee HC, Chung YH, Lee YS
- KMID: 863117
- Korean J Hepatol.
- 2002 Dec;8(4):418-427.
BACKGROUND/AIMS: Although several clinical trials have suggested that lamivudine treatment can be very effective in patients with decompensated HBV-associated cirrhosis, its role and clinical efficacy are still uncertain because... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of Interleukin-12 Gene Polymorphism with Persistence of Hepatitis B Virus Infection and Hepatocellular Carcinoma
-
Park JS, Cheong JY, Kang JK, Cho JH, Yu S, Shin HD, Park BL, Cho SW
- KMID: 782935
- Korean J Gastroenterol.
- 2007 Nov;50(5):313-318.
BACKGROUND/AIMS: Infection with hepatitis B virus (HBV) may result in various conditions. Natural course of HBV infection is influenced by various host immune factors and cytokines play a crucial... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictors of Lamivudine Resistance in Patients with Chronic Hepatitis B Virus Infection
-
Heo J, Cho M, Cho BM, Lee SM, Kim TO, Kim GH, Kang DH, Song GA
- KMID: 760719
- Korean J Hepatol.
- 2007 Jun;13(2):157-165.
BACKGROUND/AIM: Drug resistance is a major concern during nucleos(t)ide analogues therapy in patients with chronic hepatitis B virus (HBV) infections. The aim of this study was to measure the... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Lamivudine in Patients with Hepatitis B e Antigen-Negative Chronic Liver Diseases
-
Jeong ID, Park NH, Kim BC, Park JH, Seo KW, Kim DH, Joo KR, Kim DH
- KMID: 863140
- Korean J Hepatol.
- 2003 Jun;9(2):69-78.
BACKGROUND/AIMS: Lamivudine therapy is effective in inhibiting HBV replications in patients with HBeAg-negative chronic liver disease. However, the sustained response rate appears to be particularly poor, because the vast... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B
-
Sohn W, Cho JY, Kim JH, Lee JI, Kim HJ, Woo MA, Jung SH, Paik YH
- KMID: 2413121
- Clin Mol Hepatol.
- 2017 Jun;23(2):170-178.
- doi: 10.3350/cmh.2016.0086
BACKGROUND/AIMS: This study aimed to develop and validate a risk prediction model for the development of hepatocellular carcinoma (HCC) in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B... -
- CITED
-
- Close
- SHARE
-
- Close
